Updated PBAC Outcomes for March and July 2015
Page last updated: 11 December 2015
Outcomes for Nintedanib and Evolocumab from the March 2015 Pharmaceutical Benefits Advisory Committee (PBAC) meeting and Simeprevir and Nivolumab from the July 2015 PBAC meeting are now available.
